Search Results

physiological functions and in a large number of Food and Drug Administration (FDA)-approved drugs as therapeutic This review aims to explore the signaling pathways, dynamic structures, and physiological relevance in As new technologies are developed and applied to studying GPCR structure and their downstream effectors

We're gearing up for our next symposium on June 7th, focusing on Structural and Molecular Insights into and quantify the COPII concentration and anterograde transport of nascent G protein-coupled receptors Structural Insights into GPCR Function Time-resolved cryo-EM of G-protein activation by a GPCR Industry News Domain Therapeutics Prediction of Large, Complex Protein Structures Newly discovered adhesion GPCR mayo controls midgut development in Drosophila Karuna Therapeutics announces that is now part of Bristol Myers Squibb GPCR

GPCRs in Neuroscience G protein coupled receptors as targets for transformative neuropsychiatric therapeutics GPCRs in Oncology and Immunology CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment Structural and Molecular Insights into GPCR Function Lysophosphatidic acid, a simple phospholipid with Inversago Pharma will present at BBHIC 2023 Orion Biotechnology attended the Swiss Biotech Day Addex Therapeutics GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics

Congratulations to Domain Therapeutics for appointing Michael Gottlieb as Chairman and Dr. GPCRs The adhesion G-protein-coupled receptor mayo/CG11318 controls midgut development in Drosophila Structure of GPCRs in various states Reviews, GPCRs, and more G Protein-coupled Receptors (GPCRs) as Potential Therapeutics for Psychiatric Disorders Structural and Molecular Insights into GPCR Function Apelin Receptor Dimerization modulate engagement of CCR5 by chemokines by removing key electrostatic interactions Industry News Domain Therapeutics

.- Jan Steyaert, scientific director of the VIB-VUB Center for Structural Biology, Vlaams Instituut Biotechnologie combination of Steyaert’s fundamental research and his ability to apply the research to the development of therapeutic the mechanistic understanding of one of the biggest classes of pharmaceutical targets by combining structural

blockbuster weight-loss drugs Transforming Drug Discovery: Insights from Viva Biotech's GPCR and TPD Structural 2024 January 13 - 16, 2025 | PepTalk 2025 January 25 - 29, 2025 | SLAS 2025 February 15 - 16, 2025 | Structural Pharmacology GPCR Jobs GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic Hauser Group Postdoctoral Scholar – iPSC in cardiac and endothelial cell function Protein Biochemist/Structural

GPCR Symposium on Structural and Molecular Insights on GPCR Activation. Structural and Molecular Insights into GPCR Function Structural insights into ligand recognition and Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook Therapeutics Confo Therapeutics Enters Into Research Collaboration For GPCR-Targeting Antibody Discovery With AbCellera ). 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Retreat (November 2 - 4, 2023) NEW Structure

Discovery on Target’s 19th Annual GPCR-Based Drug Discovery Targeting G Protein-Coupled Receptors for New Therapeutic Industry News MBX aims for $136M IPO to take potential rival to Ascendis' Yorvipath into phase 3 Certa Therapeutics proteins for biology and health research Innovate UK announced the winners of its Transforming Cancer Therapeutics Group NEW Postdoctoral Scholar – iPSC in cardiac and endothelial cell function NEW Protein Biochemist/Structural aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL-23/IL-17 axis signal pathway Structural

GPCRs in Neuroscience G protein-coupled receptors (GPCRs) as Potential Therapeutics for Psychiatric Disorders olfactory neurons reveals subset-specific receptor expression in Caenorhabditis elegans. β- Arrestins: Structure Structural and Molecular Insights into GPCR Function Sub-millisecond conformational dynamics of the A2A Domain Therapeutics to present three posters at AACR 2023 annual meeting. Biotech Day (April 24 - 25, 2023) NEW ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics

Discovery on Target’s 19th Annual GPCR-Based Drug Discovery Targeting G Protein-Coupled Receptors for New Therapeutic September 2nd to 8th, 2024 Industry News Superluminal Medicines Closes $120 Million Series A Round Domain Therapeutics Heterodimer, TAS1R2/1R3 GPCRs in Neuroscience GPCR-Mediated Natural Products and Compounds: Potential Therapeutic and Molecular Insights into GPCR Function Insights into the structure and activation mechanism of some class B1 GPCR family members Structural basis of Frizzled 4 in recognition of Dishevelled 2 unveils

GPCR Symposium on 'GPCRs as Therapeutic Modalities' is set for September 22nd. in many tissues Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast Structural and Molecular Insights into GPCR Function Structural basis for binding of Drosophila Smaug to the GPCR Additional Chf 2.7 Million From Indivior In Extended Substance Use Disorder Research Collaboration Addex Therapeutics August 10, 2023 X4 Pharmaceuticals Closes $115 Million Loan Facility with Hercules Capital Gene-to-structure

Structural and Molecular Insights into GPCR Function Structural insight into an anti-BRIL Fab as a G-protein-coupled Industry News Addex Therapeutics to Release Q1 2023 Financial Results and Host Conference Call on May 11, 2023 Neurocrine Biosciences Reports First Quarter 2023 Financial Results Find Therapeutics welcomes critical, we cannot think about one size fits all” Dr Pina Cardarelli, Chief Scientific Officer, GPCR Therapeutics GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics

the back end to form drug discovery pact Aequorin: superior choice for GPCR calcium signalling GPCR: Structural 2024 January 13 - 16, 2025 | PepTalk 2025 January 25 - 29, 2025 | SLAS 2025 February 15 - 16, 2025 | Structural 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic Hauser Group Postdoctoral Scholar – iPSC in cardiac and endothelial cell function Protein Biochemist/Structural Advances in the molecular understanding of GPCR-arrestin complexes Cholesterol sensing goes vegetarian Structural

Orthosteric dose increases drive continuously stronger responses; NAMs and PAMs have structural ceilings PAMs assumed therapeutically viable without verifying whether they amplify affinity or efficacy. Extremely strong binders can fail in structured tissues because they saturate the periphery and never Lower-affinity alternatives may produce deeper, more therapeutically relevant coverage. Ratios—not absolutes—capture the true structure–activity shifts.

Our next symposium on Structural and Molecular Insights into GPCR Function. multicolor suite for deciphering population coding of calcium and cAMP in vivo Cryo-EM advances in GPCR structure and human genetic disease Advances and challenges in cancer immunoprevention and immune interception Structural and Molecular Insights into GPCR Function Structural bioinformatics studies of serotonin, dopamine and Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease (IBD) Domain Therapeutics

Receptor Bryan Roth  and Brian Krumm  for their excellent study on Molecular glues as potential GPCR therapeutics November 7th : Drug Disposition in Physiological Tissues as a Therapeutic Variable. December 5th : Unique Exploitable GPCR-Ligand Behaviors for Therapeutic Benefit. Hauser Group Postdoctoral Scholar – iPSC in cardiac and endothelial cell function Protein Biochemist/Structural modulation of the prostaglandin EP4 receptor GPCR Binders, Drugs, and more Molecular glues as potential GPCR therapeutics

Watch Episode 171 What happens when your protein has no known ligands, no structure, and very little Their structures are hard to determine experimentally due to poor expression and the volatility of odorant Enter AlphaFold: Predicting the “Face” of a Receptor When Alessandro began his PhD, structural models —Alessandro Nicoli For the first time, researchers had a reliable set of predicted structures to work “When they released the first structure of the odorant receptors… AlphaFold already had it, without any

receptor signaling Jiankun Lyu, Brian Shoichet, Bryan Roth, et al. for their research on AlphaFold2 structures Our symposium on Structural Insights into GPCR Activation is postponed. Mark your calendar for the GPCRs as Therapeutic Targets symposium on October 11th, 2024. GPR56, an Adhesion GPCR with Multiple Roles in Human Diseases, Current Status and Future Perspective Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator Structural

GPCRs remain one of the most prolific and fertile therapeutic drug targets. biosensors Descriptive molecular pharmacology of the δ opioid receptor (DOR): A computational study with structural protein-coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation Structural and Molecular Insights into GPCR Function Structural Mass Spectrometry Captures Residue-Resolved Comprehensive Conformational Rearrangements of a G Protein-Coupled Receptor Influence of the Water Model on the Structure

tools used to manipulate GPCR activity in an orthosteric site-independent manner to compounds with therapeutic We will discuss the historic context of pepducin development for each receptor, as well as the structural , signaling, pathophysiologic consequences, and therapeutic potential for each pepducin class."

delivers cutting-edge imaging and analysis that accelerates the discovery of new and life-changing therapeutics Their areas of focus include structural biology, protein production from Proteos, and nanoparticle characterization comprehensive approach enables Axxam to support clients worldwide in identifying and optimizing new therapeutic

only enhances our understanding of class B1 GPCR biology but also opens new avenues for developing therapeutic Tate, New insights into GPCR coupling and dimerisation from cryo-EM structures.   Current Opinion in Structural Biology, 2023. 80 : p. 102574. 2.          Graaf, C., et al., Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic

their appearance on the (illicit) drug market, e.g. as new psychoactive substances, their potential therapeutic This group of substances demonstrates a broad structural variety, leading to insufficiently described structure-activity relationships, hence illustrating the need for better functional characterization

Brian Krumm and Bryan Roth studied CryoEM structures of adhesion in GPCR CD97, filling gaps. Adhesion GPCRs CryoEM structures of adhesion in GPCR CD97: Filling in some of the gaps GPCR Activation enhance GPCR production in E. coli-based cell-free and whole cell expression systems A high-throughput structural identification of potential agonists of FFAR4 for type 2 diabetes mellitus therapy Industry News OMass Therapeutics (ANDA) Litigation PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics

We have postponed our symposium on Structural Insights into GPCR Activation to a later date. Stay tuned for our next symposium on GPCRs as Therapeutics Targets on October 11th, 2024. Post-COVID-Vaccination Syndrome With Anti-G-Protein-Coupled Receptor (GPCR) Antibodies Treated With Therapeutic neutrophil biology: inflammation, resolution and beyond Exploring GPCR signaling pathway networks as cancer therapeutic and Molecular Insights into GPCR Function Membrane mimetic-dependence of GPCR energy landscapes Structural

Modeling tools to understand how restricted diffusion  in tissues like tumors slows offset and improves therapeutic In structured, diffusion-restricted environments (e.g. brain, tumors), drugs don't just leave slowly; drug hiding in fat tissue may stay in the body for days, but if it never reaches the target site, the therapeutic

synaptic depression in dorsolateral striatum of adult male mice Methods & Updates in GPCR Research RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges Structural and Molecular Insights into GPCR Function Structural perspectives on chemokine receptors Industry News Exscientia Appoints

Sexton et al. for their job on Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP GPCR Symposia Join us on June 7th for our next symposium on Structural and Molecular Insights into GPCR , mechanisms, and drug discovery Frizzleds act as dynamic pharmacological entities Structural and Molecular into GPCR Function Molecular insights into G protein coupling specificity at a class A GPCR Cryo-EM Structure Industry News Monash University retains its N° 2 global ranking for Pharmacy and Pharmacology Addex Therapeutics

Our next symposium on Structural and Molecular Insights into GPCR Function is scheduled for June 7th. cAMP-PKA-CREB signaling pathway based on network pharmacology and bioinformatics analysis Unveiling the therapeutic News Monash University pharmaceutical scientists honoured in NHMRC Research Excellence Awards Domain Therapeutics Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adults Confo Therapeutics Development In Endocrine And Metabolic Diseases How biotech companies are using AI to design drugs GPCR Therapeutics

Why This Matters GPCR research demands integration — pharmacology, structural biology, signaling pathways A shared environment lowers friction between these specialties, making innovation structurally inevitable Engineering Collaboration: The Monash Lab Model Traditional academic labs mirror feudal structures. The structure you train in often matters more than the experiment you start with. Monash turned structure itself into a collaboration tool.